Please note that in the abstract submission system you will be asked to choose the main topic first, and then to chose the sub-topic:
- AS01- Surgery – IPSO – if accepted, the abstract will be presented in the IPSO programme
-
- AS01.a Neuroblastoma
- AS01.b Renal or Germ cell tumours
- AS01.c Hepato-pancreatic malignancies
- AS01.d Sarcoma
- AS01.e New technologies, techniques and other tumours
- AS02- Radiation Oncology – PROS – if accepted, the abstract will be presented in the PROS programme
-
- AS02.a Neuroblastoma
- AS02.b Renal or Germ cell tumours
- AS02.c Hepato-pancreatic malignancies
- AS02.d Sarcoma
- AS02.e New technologies, techniques and other tumours
- AS03- CCI – Childhood Cancer International – focused for parents of children with cancer – if accepted, the abstract will be presented in the CCI programme
- AS04- Nursing – if accepted, the abstract will be presented in the Nursing programme
- AS04.a Education (Programmes, strategies, or resources designed to build knowledge and skills among nurses, patients, and families in paediatric oncology care.)
- AS04.b Research (Original studies using established research methodologies to generate new evidence to advance paediatric oncology nursing practice and improve patient outcomes)
- AS04.c Quality Improvement/Practice Project (Initiatives aimed at enhancing processes, care delivery, and patient experiences through measurable improvements in practice.)
- AS04.d SIOP Baseline Nursing Standards for Low- and Middle-income Countries (Work focused on implementing the six baseline standards to ensure consistency and safety in paediatric oncology nursing globally.)
- AS05- SIOP Scientific Programme
- AS05.a Acute Lymphoblastic Leukaemia
- AS05.b Myeloid Leukemias, Myelodysplastic and Myeloproliferative Syndromes
- AS05.c Lymphomas
- AS05.d Neuroblastoma
- AS05.e Renal Tumours
- AS05.f Bone Tumours
- AS05.g Soft Tissue Sarcomas
- AS05.h Retinoblastoma
- AS05.i Liver Tumours
- AS05.j Germ Cell Tumours
- AS05.k Rare Tumours and Histiocytosis
- AS05.l Brain Tumours
- AS05.m Pharmacogenomics and New Therapeutics
- AS05.n Tumour Biology and Genetics
- AS05.o Immunology, Immunotherapy and Stem Cell Transplantation development
- AS05.p Psychosocial (PPO)
- AS05.q Epidemiology
- AS05.r Global Health, Policy and Advocacy (Only select this category if your abstract addresses broader systemic challenges, regional policy issues, or context-specific barriers that
- AS05.s Survivorship/late toxicity
- AS05.t Early treatment related- toxicity
- AS05.u1 Supportive Care – Quality of life
- AS05.u2 Supportive Care – Nutrition
- AS05.u3 Supportive Care – Rehabilitation
- AS05.u4 Supportive Care-Palliative Care